Auriga Upgrades Protalix BioTherapeutics (PLX) to Buy
Tweet Send to a FriendGet Alerts PLX Hot Sheet
Price: $5.21 --0%
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 8
Rating Summary:
2 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 8
Trade PLX Now!
Auriga upgraded Protalix BioTherapeutics (NYSE: PLX) from Hold to Buy, price target raised from $8 to $9.
For an analyst ratings summary and ratings history on Protalix BioTherapeutics click here. For more ratings news on Protalix BioTherapeutics click here.
Shares of Protalix BioTherapeutics closed at $6.73 yesterday, with a 52 week range of $4.06-$7.70.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Protalix BioTherapeutics click here. For more ratings news on Protalix BioTherapeutics click here.
Shares of Protalix BioTherapeutics closed at $6.73 yesterday, with a 52 week range of $4.06-$7.70.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- UBS Raises PT on Tesoro (TSO)
- Wunderlich Securities Upgrades Con-way (CNW) to Buy
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
Auriga
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
